Why I can't buy Coca-Cola Amatil Ltd shares today

The Coca-Cola Amatil Ltd (ASX:CCL) share price has continued its recent falls, but I still can't bring myself to buy it shares for my portfolio.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Coca-Cola Amatil Ltd (ASX: CCL) share price has continued its recent falls, but I still can't bring myself to buy any for my portfolio.

Coca-Cola Amatil: Losing Fizz

CCL share price
Source: Google Finance

The above chart compares Coca-Cola Amatil, the Australian and Kiwi distributor of Coca-Cola and other products; and The Coca-Cola Company, which owns the global rights to the brand. It is also a major shareholder in the Australian distributor.

As can be seen, it has been a tough run for Coca-Cola Amatil shareholders over the past five years.

Some might argue Amatil's woes initially appeared with the rise of a healthier consumer and a resurgent marketing campaign by PepsiCo Inc.

Two years ago, I published this chart:

It shows Coca-Cola Company's profit per share falling over time, while PepsiCo appears to be gaining ground.

Since then, The Coca-Cola Company's profit per share has continued to fall while PepsiCo's is higher than it was two years ago.

Closer to home, Amatil's sales have remained quite steady and a fresh injection from its global parent should have bolstered its marketing efforts. Unfortunately, its profit is down.

That's why, using ratios, Amatil's shares still appear expensive despite the fall from grace.

Foolish Takeaway

With more consumers demanding healthier products, in a saturated and competitive market, I find it hard to see Coca-Cola Amatil shares going on to be a comprehensive market-beating investment. That's why I'm looking elsewhere for new investment opportunities, at least until we see some signs of a turnaround in its fundamentals.

Motley Fool contributor Owen Raszkiewicz has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »